Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 65,820 shares at $87.67 ($5.8M) on 2025-10-14, disclosed to the SEC on 2025-10-15.
Scheduled sale ($5.8M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.90 | 6,138 | $540K | 9.4% |
| 2 | $87.90 | 6,138 | $540K | 9.4% |
| 3 | $88.73 | 12,266 | $1.1M | 18.9% |
| 4 | $88.73 | 12,266 | $1.1M | 18.9% |
| 5 | $89.22 | 1,596 | $142K | 2.5% |
| 6 | $89.22 | 1,596 |
| $142K |
| 2.5% |
| 7 | $85.75 | 12,280 | $1.1M | 18.3% |
| 8 | $86.63 | 5,820 | $504K | 8.7% |
| 9 | $86.63 | 5,820 | $504K | 8.7% |
| 10 | $87.67 | 1,700 | $149K | 2.6% |
| 11 | $88.90 | 200 | $18K | 0.3% |
| Total | $87.64 avg | 65,820 | $5.8M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |